Medicare Enrolled
Dr. Ross Vogelgesang, MD
Pain Medicine · Olympia, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vogelgesang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vogelgesang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vogelgesang
Dr. Ross Vogelgesang is a pain medicine specialist in Olympia, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vogelgesang performed 2,704 Medicare services across 1,095 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vogelgesang received a total of $22,446 from 49 pharmaceutical and/or device companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vogelgesang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in WA
$22,446 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,704
Medicare services
Top 16% in WA for pain medicine
1,095
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,598 | $58 | $200 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
210 | $0 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $87 | $205 |
| Contrast dye for imaging, lower concentration | 172 | $0 | $10 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
79 | $150 | $424 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
59 | $42 | $137 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
59 | $90 | $234 |
| New patient office visit, complex (60-74 min) | 45 | $159 | $372 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $124 | $259 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
38 | $185 | $425 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
35 | $197 | $427 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
34 | $102 | $243 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
33 | $1,418 | $2,983 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $51 | $145 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
19 | $203 | $643 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
17 | $210 | $424 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $40 | $160 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
14 | $204 | $1,388 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
14 | $62 | $631 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $120 | $293 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,446
Total received (2018-2024)
Avg $3,207/year across 7 years
Top 9% in WA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
506
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,579 (69.4%)
Other
Charitable contributions, space rental, and other categories
$4,696 (20.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,172 (9.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,709
2023
$3,005
2022
$631
2021
$1,038
2020
$7,353
2019
$3,365
2018
$2,346
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$4,201
Nevro Corp.
$324
SI-BONE, INC.
$60
Nalu Medical, Inc.
$32
PFIZER INC.
$20
Merz Pharmaceuticals, LLC
$19
Vertos Medical, Inc.
$19
Virtus Pharmaceuticals LLC
$18
Ultragenyx Pharmaceutical Inc.
$16
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$11,072
Medtronic, Inc.
$4,711
Genesys Orthopedics Systems, L.L.C.
$1,036
Collegium Pharmaceutical, Inc.
$757
Daiichi Sankyo Inc.
$505
Zyla Life Sciences, Inc.
$439
BioDelivery Sciences International, Inc.
$384
Medtronic USA, Inc.
$366
Zyla Life Sciences
$358
Egalet US Inc
$357
PFIZER INC.
$196
Vertos Medical, Inc.
$174
Scilex Pharmaceuticals Inc.
$174
SI-BONE, INC.
$159
AbbVie Inc.
$155
Sentynl Therapeutics, Inc.
$126
Kaleo, Inc.
$106
Assertio Therapeutics, Inc.
$100
Abbott Laboratories
$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
Allergan Inc.
$88
Amgen Inc.
$86
ABBVIE INC.
$69
Nalu Medical, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$64
US WorldMeds, LLC
$62
SPR Therapeutics, Inc
$47
ARBOR PHARMACEUTICALS, INC.
$47
Biohaven Pharmaceuticals, Inc.
$46
Horizon Therapeutics plc
$42
Virtus Pharmaceuticals LLC
$41
Boston Scientific Corporation
$34
Teva Pharmaceuticals USA, Inc.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$32
Allergan, Inc.
$32
Pernix Therapeutics Holdings, Inc.
$32
Kowa Pharmaceuticals America, Inc.
$31
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$27
Relievant Medsystems, Inc.
$23
RedHill Biopharma Inc.
$22
AstraZeneca Pharmaceuticals LP
$22
Merz Pharmaceuticals, LLC
$19
BOSTON SCIENTIFIC CORPORATION
$19
Vertical Pharmaceuticals, LLC
$17
Evofem Biosciences, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$16
Lilly USA, LLC
$13
Jazz Pharmaceuticals Inc.
$13
Purdue Pharma L.P.
$13
Top 3 companies account for 74.9% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AJOVY · ARYMO ER · Accurian · Aimovig · BELBUCA · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · Cambia · DUEXIS · Dojolvi · EMGALITY · EVZIO · Evzio · GENERAL - THERAPIES · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · N'VISION · NURTEC ODT · Nalu Neurostimulation System · Omnia · Phexxi · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · RELISTOR · SI Joint · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYMPROIC · SYNCHROMED · Seglentis · Senza · Senza Spinal Cord Stimulation System · UBRELVY · Uloric · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pain medicine in WA.
Geographic Context
Pain medicines within 10 mi
4
Per 100K population
1.3
County median income
$93,985
Nearest hospital
CAPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vogelgesang is a mixed practice specialist, with above-average Medicare volume (top 16% in WA), with low-engagement industry engagement in the top 9% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vogelgesang experienced with drug screening test?
Based on Medicare claims data, Dr. Vogelgesang performed 1,598 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vogelgesang receive payments from pharmaceutical companies?
Yes. Dr. Vogelgesang received a total of $22,446 from 49 companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vogelgesang's costs compare to other pain medicines in Olympia?
Dr. Vogelgesang's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vogelgesang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Olympia
Browse pain medicines in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in WA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in WA
Which WA pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Genesys Orthopedics Systems, L.L.C. Payments to Doctors
See all physicians who received payments from Genesys Orthopedics Systems, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology